Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer

INTRODUCTION: One out of six adults has symptoms of overactive bladder (OAB). Antimuscarinic medication is the main pharmacological group used in the treatment of OAB. In preclinical studies, antimuscarinic compounds have been found to inhibit cell proliferation in lung cancer and colon cancer. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Löfling, Lukas, Sundström, Anders, Kieler, Helle, Bahmanyar, Shahram, Linder, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350836/
https://www.ncbi.nlm.nih.gov/pubmed/30774448
http://dx.doi.org/10.2147/CLEP.S186842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350836/
https://www.ncbi.nlm.nih.gov/pubmed/30774448
http://dx.doi.org/10.2147/CLEP.S186842

Ejemplares similares